影像学：规范功能磁共振成像在前列腺癌中的应用 - Suppr

Suppr

超能文献

Imaging: standardizing the use of functional MRI in prostate cancer.

作者信息

deSouza Nandita M, Sala Evis

出版信息

Nat Rev Urol. 2011 Mar;8(3):127-9. doi: 10.1038/nrurol.2011.12. Epub 2011 Feb 15.

DOI:10.1038/nrurol.2011.12

PMID:21321573

Abstract

摘要

相似文献

Imaging: standardizing the use of functional MRI in prostate cancer.

Nat Rev Urol. 2011 Mar;8(3):127-9. doi: 10.1038/nrurol.2011.12. Epub 2011 Feb 15.

Synopsis of the PI-RADS v2 Guidelines for Multiparametric Prostate Magnetic Resonance Imaging and Recommendations for Use.

Eur Urol. 2016 Jan;69(1):41-9. doi: 10.1016/j.eururo.2015.08.038. Epub 2015 Sep 8.

METastasis Reporting and Data System for Prostate Cancer: Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate Cancer.

Eur Urol. 2017 Jan;71(1):81-92. doi: 10.1016/j.eururo.2016.05.033. Epub 2016 Jun 14.

Oncologist criticises NICE for not recommending wider use of MRI in prostate cancer.

BMJ. 2014 Jan 10;348:g174. doi: 10.1136/bmj.g174.

[Magnetic resonance imaging in the diagnosis of prostate cancer: problems and capabilities].

Vestn Rentgenol Radiol. 2013 Sep-Oct(5):50-6.

PIRADS 2.0: what is new?

Diagn Interv Radiol. 2015 Sep-Oct;21(5):382-4. doi: 10.5152/dir.2015.15099.

The 2010 NCCN clinical practice guidelines in oncology on prostate cancer.

J Natl Compr Canc Netw. 2010 Feb;8(2):145. doi: 10.6004/jnccn.2010.0010.

NICE guidelines on Prostate Cancer Active Surveillance: is UK practice leading the world?

BJU Int. 2015 Jan;115(1):12-3. doi: 10.1111/bju.12752. Epub 2014 Oct 18.

The use of MRI scanning to triage patients.

Br J Nurs. 2011;20(20):1310-4. doi: 10.12968/bjon.2011.20.20.1310.

The state of prostate MRI in 2013.

Oncology (Williston Park). 2013 Apr;27(4):262-70.

本文引用的文献

Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting.

Eur Urol. 2011 Apr;59(4):477-94. doi: 10.1016/j.eururo.2010.12.009. Epub 2010 Dec 21.

Diffusion-weighted magnetic resonance imaging for monitoring prostate cancer progression in patients managed by active surveillance.

Br J Radiol. 2011 Jan;84(997):31-7. doi: 10.1259/bjr/14556365.

Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2-weighted, dynamic contrast-enhanced and diffusion-weighted imaging.

BJU Int. 2011 May;107(9):1411-8. doi: 10.1111/j.1464-410X.2010.09808.x. Epub 2010 Nov 2.

Diffusion-weighted MRI at 3 T for the evaluation of prostate cancer.

AJR Am J Roentgenol. 2010 Jun;194(6):1461-9. doi: 10.2214/AJR.09.3654.

MRI in the detection of prostate cancer: combined apparent diffusion coefficient, metabolite ratio, and vascular parameters.

AJR Am J Roentgenol. 2009 Dec;193(6):1583-91. doi: 10.2214/AJR.09.2540.

Dynamic contrast-enhanced magnetic resonance imaging in the evaluation of the prostate.

Top Magn Reson Imaging. 2008 Dec;19(6):273-84. doi: 10.1097/RMR.0b013e3181aacdc2.

Evaluation of the potential of diffusion-weighted imaging in prostate cancer detection.

Acta Radiol. 2007 Jul;48(6):695-703. doi: 10.1080/02841850701349257.

A method for pharmacokinetic modelling of dynamic contrast enhanced MRI studies of rapidly enhancing lesions acquired in a clinical setting.

Phys Med Biol. 2006 May 7;51(9):N187-97. doi: 10.1088/0031-9155/51/9/N03. Epub 2006 Apr 19.

Magnetic resonance imaging and magnetic resonance spectroscopic imaging of prostate cancer.

Nat Clin Pract Urol. 2005 Sep;2(9):434-42. doi: 10.1038/ncpuro0296.

Development and aftercare of clinical guidelines: the balance between rigor and pragmatism.

JAMA. 2001 Sep 26;286(12):1509-11. doi: 10.1001/jama.286.12.1509.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验